FDA approves Abbott Vascular stent study
4th Jun 2006, 05:54 GMT
Abbott Vascular said its stent placement to treat severe peripheral arterial disease below the knee has been cleared by the FDA for clinical trials in hospitals throughout the country.
FDA approves Abbott Vascular stent study related news:
- FDA approves Abbott Vascular stent study — bizjournals.com Health Care:Industry Regulation headlines
- FDA Approves 1st US Study of Stent Placement to Treat Arterial Blockages Below the Knee — Angiography/ Cardiac Cath News from StratCenter.com
- FDA Clears Abbott Stent Trial — Angiography/ Cardiac Cath News from StratCenter.com
- CytoDyn Sponsored Team Hope Raises the Most Money for Emory University and FDA Approves Abbott Vascular Stent Study — Financial News USA (OTC: FNWU)
- FDA Approves First U.S. Study Of Stent Placement To Treat Arterial Blockages Below The Knee — Medical News Today RSS/XML Feed
- FDA Clears Boston Scientific System for Removing Clots from Arteries — Angiography/ Cardiac Cath News from StratCenter.com
- FDA approves CollaGenex rosacea drug — Pharmaceutical Business Review Latest News
- FDA approves Merck's shingles vaccine — Pharmaceutical Business Review Latest News
- Lupin gets FDA nod for generic antibiotic — Pharmaceutical Business Review Latest News
- Gillard calls Abbott a 'snivelling grub' — NATIONAL
Latest news from Angiography/ Cardiac Cath News from StratCenter.com:
- Thinking Systems Releases Enhanced PET-CT Functions for Its ThinkingPACS
- Tallahassee Memorial Hospital at the Forefront in Treatment of Heart Attack Patients
- Preliminary Long-Term Clinical Data Show Promising Results for the CYPHER Sirolimus-eluting Coronary Stent in Patients With Multi-Vessel Disease